The United States represents the largest market for Remicade drugs Market in North America, driven by a high prevalence of autoimmune disorders such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis. Strong healthcare infrastructure, favorable reimbursement policies, and widespread access to biologic therapies continue to support market growth. The global Remicade Drug...